Home NDC 13537-318 ESIKA
Product NDC 13537-318
11-digit product format 135370318
Labeler code 13537
Product ID 13537-318_d6c64fef-cbe6-4ccd-92d4-803463c61be2
Type HUMAN OTC DRUG
Nonproprietary name OCTINOXATE
Dosage form POWDER
Route TOPICAL
Labeler Ventura Corporation (San Juan, P.R)
Application part352
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2011-05-17
Marketing end 0000-00-00
Substance OCTINOXATE
Active strength 0 g/g
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 13537-318-02 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 13537-318-02 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 13537-318-02 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 13537-318-02 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 13537-318-02 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 13537-318-02 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 13537-318-02 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 13537-318-02 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 13537-318-02 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 13537-318-02 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 13537-318-02 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 13537-318-02 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 13537-318-02 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 13537-318-02 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 13537-318-02 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 13537-318-02 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 13537-318-02 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 13537-318-02 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 13537-318-02 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 13537-318-02 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 13537-318-02 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product I Inactivated by FDA 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 13537-318-02 I Inactivated by FDA 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded OCTINOXATE ACTIVE INGREDIENT 4Y5P7MUD51 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 OCTINOXATE ACTIVE MOIETY 4Y5P7MUD51 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 BUTYLATED HYDROXYANISOLE INACTIVE INGREDIENT REK4960K2U ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 BUTYLATED HYDROXYTOLUENE INACTIVE INGREDIENT 1P9D0Z171K ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CANDELILLA WAX INACTIVE INGREDIENT WL0328HX19 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CARNAUBA WAX INACTIVE INGREDIENT R12CBM0EIZ ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CETEARYL GLUCOSIDE INACTIVE INGREDIENT 09FUA47KNA ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CETOSTEARYL ALCOHOL INACTIVE INGREDIENT 2DMT128M1S ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CHOLESTEROL INACTIVE INGREDIENT 97C5T2UQ7J ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CYCLOMETHICONE INACTIVE INGREDIENT NMQ347994Z ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CYCLOMETHICONE 5 INACTIVE INGREDIENT 0THT5PCI0R ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CYCLOMETHICONE 6 INACTIVE INGREDIENT XHK3U310BA ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 DIAZOLIDINYL UREA INACTIVE INGREDIENT H5RIZ3MPW4 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 ETHYLHEXYL PALMITATE INACTIVE INGREDIENT 2865993309 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 HEXYL LAURATE INACTIVE INGREDIENT 4CG9F9W01Q ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 MICROCRYSTALLINE WAX INACTIVE INGREDIENT XOF597Q3KY ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 OCTYLDODECANOL INACTIVE INGREDIENT 461N1O614Y ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 PETROLATUM INACTIVE INGREDIENT 4T6H12BN9U ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 POLYGLYCERYL-4 ISOSTEARATE INACTIVE INGREDIENT 820DPX33S7 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 SOYBEAN INACTIVE INGREDIENT L7HT8F1ZOD ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 TALC INACTIVE INGREDIENT 7SEV7J4R1U ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 TRIETHOXYCAPRYLYLSILANE INACTIVE INGREDIENT LDC331P08E ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 WATER INACTIVE INGREDIENT 059QF0KO0R ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1 YELLOW WAX INACTIVE INGREDIENT 2ZA36H0S2V ESIKA (OCTINOXATE) POWDER [VENTURA CORPORATION (SAN JUAN, P.R)] 1